Clinical Trials Logo

Filter by:
NCT ID: NCT04529512 Not yet recruiting - Clinical trials for Ocular Disease Requiring Surgery

INtravitreal and Aqueous Dexamethasone Levels After DEXtenza

INDEX
Start date: March 2021
Phase: Phase 4
Study type: Interventional

A prospective, open-label, interventional study to determine intraocular concentration levels of dexamethasone following use of the DEXTENZA® implant.

NCT ID: NCT04529044 Not yet recruiting - Clinical trials for Anatomic Stage IV Breast Cancer AJCC v8

177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer

Start date: September 1, 2022
Phase: Phase 2
Study type: Interventional

This phase II trial investigates how well 177Lu-DOTATATE works in treating patients with breast cancer that is stage IV or has come back (recurrent). 177Lu-DOTATATE may shrink or destroy the tumor or circulating breast cancer stem cells if they show evidence of the SSTR2. 177Lu-DOTATATE is a targeted therapy that uses DOTATATE, linked to a radioactive agent called 177Lu. DOTATATE attaches to tumor cells with SSTR2 and delivers 177Lu to kill them. Giving 177Lu-DOTATATE may help decrease the number and size of tumors and the number of circulating cancer stem cells in patient's blood for the treatment of patients with breast cancer positive for SSTR2.

NCT ID: NCT04527445 Not yet recruiting - Overactive Bladder Clinical Trials

Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement

Start date: June 30, 2024
Phase: N/A
Study type: Interventional

Fluoroscopy is performed when placing a lead during a sacral neuromodulation procedure. During lead placement, subjects will receive either conventional or experimental fluoroscopic settings. The radiation exposure will be compared between the two groups.

NCT ID: NCT04525976 Not yet recruiting - Clinical trials for Respiratory Tract Infections

A Phase I Study of the EmitBio™ RD19 Device to Prevent SARS-CoV-2 and COVID-19

Start date: August 31, 2020
Phase: N/A
Study type: Interventional

This first-in-man (FIM) phase I study will evaluate the acute safety, tolerability, and device acceptability for use among 25 healthy volunteers between the age of 18 and 45. Safety and tolerability (local reactogenicity) will be assessed actively at screening (baseline set), and study days 1, 7 and 14, and on non-clinic visit days by collection of these data by history during clinic visits via a memory aid (diary cards). Metabolic, liver and kidney safety laboratory evaluations, as well as urinalysis, will be performed at screening and at Day 14 or early termination (and potentially during unscheduled) clinic visits. Hematological safety assessments will be performed at all visits.

NCT ID: NCT04523363 Not yet recruiting - Clinical trials for Prediabetes; Complicating Pregnancy

Metformin Versus Standard of Care Treatment in Pregnant Women With Prediabetes

Start date: June 1, 2025
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess if metformin reduces adverse outcomes associated with prediabetes in pregnancy. Our hypothesis is that pregnant women with prediabetes who are treated with metformin will show a greater reduction in large for gestational age infants at birth compared to women treated with the standard of care.

NCT ID: NCT04515810 Not yet recruiting - Clinical trials for Malignant Solid Neoplasm

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

Start date: October 1, 2024
Phase: N/A
Study type: Interventional

This clinical trial tests a new mobile health application (app) called Planning Advance Care Together (PACT) to help people with cancer talk about and plan for advance care planning (the care they would want if they were unable to communicate) with their loved ones and doctors. The development of the PACT mobile app may help future patients incorporate their social network (typically, but not exclusively, family) into the advance care planning process.

NCT ID: NCT04515784 Not yet recruiting - Clinical trials for Stress Disorders, Post-Traumatic

Safety Aid Reduction Treatment for PTSD Among Veterans

START-PTSD
Start date: June 3, 2024
Phase: N/A
Study type: Interventional

The purpose of this project is to examine the efficacy of a safety aid reduction treatment (START), compared to a wait-list control, among Veterans with posttraumatic stress disorder (PTSD). It is hypothesized that participation in START, compared to a wait-list control, will be associated with decreased PTSD symptom severity immediately and over time.

NCT ID: NCT04506333 Not yet recruiting - Blood Pressure Clinical Trials

Validation of A&D UA-651 in Children

Start date: August 2020
Phase: N/A
Study type: Interventional

This study will determine if the A&D UA-651 blood pressure monitor is valid in children.

NCT ID: NCT04502277 Not yet recruiting - Candidiasis Clinical Trials

Bioavailability of Flucanazole

Start date: September 1, 2020
Phase: Early Phase 1
Study type: Interventional

The Objective of This Study Was an Open-label, Randomized, 2-way Crossover to Compare the Single-dose Relative Bioavailability of Flucanazole 40mgm/ml 35 ml Suspension and Pfizer (Diflucan®) 40 mg/ml 35 ml Fluconazole Suspension Under Fed Condition

NCT ID: NCT04501016 Not yet recruiting - Tobacco Cessation Clinical Trials

A Stepped Care Approach to Treating Tobacco Use in Rural Veterans

Stepped Care
Start date: September 2020
Phase: Phase 2/Phase 3
Study type: Interventional

Tobacco use remains prevalent among Veterans. Although effective smoking cessation interventions exist, long-term term quit rates remain sub-optimal. The project will investigate the feasibility of a stepped care approach to treating tobacco use that includes enhancements based on initial response to treatment to augment the investigators' existing tailored tobacco treatment intervention.